Stocks
Armata Pharmaceuticals, Inc.ARMP
AMEXHealthcareBiotechnology$3.64
Price as of · delayed, not real-time
A clinical-stage biopharmaceutical company developing bacteriophage therapies to treat antibiotic-resistant bacterial infections. Its lead candidate targets Pseudomonas aeruginosa in cystic fibrosis patients, with additional programs in diabetic foot infections and prosthetic joint infections. Investors track ARMP for its exposure to the growing antimicrobial resistance space and the potential for orphan drug designations.
52W Range: $2.75-$14.98
Congressional Interest in Armata Pharmaceuticals, Inc. (ARMP)
No congressional trades have been disclosed for Armata Pharmaceuticals, Inc. (ARMP) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading ARMP?
No congressional trades found for this stock.